Find clinical trials for breast cancer. Search for breast cancer clinical trials in different cities and states across the United States.
Filter
1
Filter results
Results: 1,182
Active & ResponsiveNew
Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Nashville TN
Sponsor: Vandana Abramson
Sex: All
Age: 18+
Code: NCT07016399
Phase2, Recruiting
Active & ResponsiveNew
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
for
Prostate Cancer Castration-resistant Prostate Cancer,
Location: Grand Rapids MI, Irving TX, San Antonio TX,
Sponsor: MBrace Therapeutics
Sex: All
Age: 18+
Code: NCT07145255
Phase1, Phase2, Recruiting
Active & Responsive
Web-Based Communication Education for Breast Cancer Survivorship Care
for
Breast Cancer
Location: Washington DC
Sponsor: Georgetown University
Sex: Female
Age: 18+
Code: NCT03413332
Recruiting
Active & Responsive
Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters)
for
Breast Cancer
Location: Washington D.C. DC, Richmond VA
Sponsor: Virginia Commonwealth University
Sex: Female
Age: 18+
Code: NCT05334732
Recruiting
Active & Responsive
Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs
for
Lung Cancer Diagnosis, Colorectal Cancer (Diagnosis),
Location: Brooklyn NY, Jamaica NY, New York NY, Staten Island NY
Sponsor: NYU Langone Health
Sex: All
Age: 18+
Code: NCT06559059
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
for
Breast Cancer Female
Location: Charlottesville VA, Fairfax VA, Richmond VA
Sponsor: University of Virginia
Sex: Female
Age: 65+
Code: NCT06507618
Phase3, Recruiting
Active & Responsive
A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)
for
Leptomeningeal Disease, Triple Negative Breast Cancer,
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT05809752
Phase1, Recruiting
Active & Responsive
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
for
PIK3CA Mutation, Solid Tumor, Adult,
Location: Tucson AZ, San Diego CA, Denver CO, New Haven CT,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05216432
Phase1, Recruiting
Active & Responsive
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
for
Metastatic Breast Cancer
Location: Chandler AZ, Gilbert AZ, Glendale AZ, Mesa AZ,
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 65+
Code: NCT06377852
Phase3, Recruiting
Active & Responsive
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
for
Breast Cancer Screening, Breast Carcinoma in Situ,
Location: Birmingham AL, Irvine CA, Los Angeles CA, Sacramento CA,